An Interview with Ana Boban
With a clear vision grounded in continuity, innovation and collaboration, Ana Boban, the new EAHAD President, outlined her priorities for the years ahead during the Annual General Meeting held on Tuesday, 4th February 2026 in Dublin, on the occasion of the EAHAD 2026 Congress.
Ana, what are the main pillars of your presidency?
My focus is rooted in strengthening what EAHAD already does well, while ensuring we continue to grow in a structured and forward-thinking way.
Our Working Groups are truly the engine of EAHAD. They bring expertise and practical impact. I would like to see their role further strengthened and their initiatives more visible either through publishing of recommendations or guidelines. The use of digital media and digital tools should help us in promoting the work of our WGs.
Through the process of accreditation of haemophilia centres across Europe, we will continue to promote, educate and improve the standards of care in European countries. Although healthcare systems differ locally in terms of funding and administration, we must strive towards harmonised standards of care anywhere in Europe.
Finally, supporting early-career clinicians and scientists is another essential area. EAHAD is already very strong in this area and we will continue to use our grants and educational activities in building the next generation.
Digital innovation is transforming medicine. How does this fit into your vision?
This is an exciting area of development. I believe we need to enhance our digital footprint and increase our global visibility. This means improving how we communicate, how we share knowledge and how we connect within EAHAD and with our community beyond physical meetings.
I am particularly interested in exploring the role of artificial intelligence in haemophilia and bleeding disorders. I hope EAHAD will soon start its own practical research in this area.
Another important example of digital is the use of electronic voting we had for the first time in January 2026. As we grow as a society, we need to use more of digital tools that will help us in making decisions faster and ease the administrative burden.
How do you see EAHAD growing strategically?
The EAHAD Congress is already a flagship event, but I believe we can further position it as the leading global association dedicated to haemophilia and bleeding disorders.
At the same time, we must ensure that EAHAD’s activities extend beyond the annual Congress. Promoting Haemophilia Journal as our official journal is another important step in reinforcing our identity.
Membership growth is important as well. A larger, engaged membership strengthens our influence and ensures we remain representative of the European haemophilia community. Again, having digital tools at our disposal, we will be able to manage and engage our larger membership base.
Collaboration seems central to your approach.
Strategic partnerships with other societies and organisations are essential. We signed the Memorandum of Understanding with EHC, WFH and ISTH over the past years. We will continue to collaborate with other societies but keeping in mind the central role of EAHAD in haemophilia and inherited bleeding disorders. We must keep working together efficiently and avoid duplication of efforts and maximise final impact.
What message would you like to leave with EAHAD members?
EAHAD has strong foundations, built through years of dedication and collaboration. My aim is to build on that strength, to modernise it where necessary and to prepare it for the future.